E.E.S Drug Patent Profile
✉ Email this page to a colleague
When do E.e.s patents expire, and what generic alternatives are available?
E.e.s is a drug marketed by Azurity and Arbor Pharms Llc and is included in four NDAs.
The generic ingredient in E.E.S is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E.e.s
A generic version of E.E.S was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for E.E.S
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in E.E.S? | E.E.S excipients list |
DailyMed Link: | E.E.S at DailyMed |
US Patents and Regulatory Information for E.E.S
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | E.E.S. | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Azurity | E.E.S. | erythromycin ethylsuccinate | TABLET, CHEWABLE;ORAL | 050297-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 200 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-002 | Aug 12, 1982 | BX | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |